BR9701895B1 - estrogenic agents and pharmaceutical composition comprising them. - Google Patents

estrogenic agents and pharmaceutical composition comprising them.

Info

Publication number: BR9701895B1
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; estrogenic agents; estrogenic; agents; pharmaceutical
Prior art date: 1996-04-19

Application number

BR9701895A

Other languages

Portuguese (pt)

Other versions

BR9701895A (en

Inventor

Chris Paul Miller

Michael David Collini

Bach Dinh Tran

Arthur Attilio Santilli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-19

Filing date

1997-04-22

Publication date

2010-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24541937&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9701895(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-04-04 Priority claimed from US08/833,271 external-priority patent/US5998402A/en

1997-04-22 Application filed filed Critical

1998-11-10 Publication of BR9701895A publication Critical patent/BR9701895A/en

2010-08-10 Publication of BR9701895B1 publication Critical patent/BR9701895B1/en

Links

BR9701895A 1996-04-19 1997-04-22 estrogenic agents and pharmaceutical composition comprising them. BR9701895B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63397496A	1996-04-19	1996-04-19
US08/833,271 US5998402A (en)	1996-04-19	1997-04-04	2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

Publications (2)

Publication Number	Publication Date
BR9701895A BR9701895A (en)	1998-11-10
BR9701895B1 true BR9701895B1 (en)	2010-08-10

Family

ID=24541937

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9701895A BR9701895B1 (en)	1996-04-19	1997-04-22	estrogenic agents and pharmaceutical composition comprising them.

Country Status (5)

Country	Link
BR (1)	BR9701895B1 (en)
CA (1)	CA2203079C (en)
ID (1)	ID16604A (en)
TW (1)	TW381093B (en)
ZA (1)	ZA973302B (en)

1997
- 1997-04-16 TW TW86104919A patent/TW381093B/en not_active IP Right Cessation
- 1997-04-17 ID IDP971301A patent/ID16604A/en unknown
- 1997-04-17 ZA ZA973302A patent/ZA973302B/en unknown
- 1997-04-18 CA CA 2203079 patent/CA2203079C/en not_active Expired - Fee Related
- 1997-04-22 BR BR9701895A patent/BR9701895B1/en active IP Right Grant

Also Published As

Publication number	Publication date
CA2203079A1 (en)	1997-10-19
ID16604A (en)	1997-10-23
ZA973302B (en)	1998-10-19
TW381093B (en)	2000-02-01
BR9701895A (en)	1998-11-10
CA2203079C (en)	2006-12-05

Similar Documents

Publication	Publication Date	Title
BRPI9810519B1 (en)	2012-02-22	4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
BR9710372B1 (en)	2013-02-05	compound, and pharmaceutical composition.
CY2013008I2 (en)	2015-08-05	APPETITE SUPPRESSANT PEPTIDE, COMPOSITIONS AND USE THEREOF
NL300416I2 (en)	2010-02-01	Estrogenic agents
NO20003254D0 (en)	2000-06-22	Anti-estrogenic steroids and pharmaceutical compositions containing the same, and their use
NO971814L (en)	1997-10-20	Estrogenic agents
BR9504791B1 (en)	2010-10-05	polypeptide compound and pharmaceutical composition.
BR9607851B1 (en)	2009-01-13	combination and pharmaceutical formulation.
ID18352A (en)	1998-04-02	PHARMACEUTICAL COMPOSITIONS
NO980546D0 (en)	1998-02-09	Pharmaceutical agents
BR9707812A (en)	1999-07-27	Pharmaceutical Compound Compound and Compound Use
BR9509688A (en)	1997-09-30	Pharmaceutical composition and composition
ID16781A (en)	1997-11-13	PHARMACEUTICAL FORMULATIONS
ID29294A (en)	2001-08-16	PHARMACEUTICAL COMPOSITION
BR9707657A (en)	1999-07-27	Benzothiophene formulations containing the same and methods
BR9708248A (en)	1999-07-27	Benzothiophene formulations containing the same and methods
BR9507768A (en)	1997-09-02	Pharmaceutical composition
DZ1926A1 (en)	2002-02-17	Pharmaceutical formulations.
MA26531A1 (en)	2004-12-20	PHARMACEUTICAL COMPOSITION
BR9709406B1 (en)	2009-05-05	substituted alkyloxyamino fluorenones and pharmaceutical composition containing them.
ID18698A (en)	1998-04-30	PHARMACEUTICAL COMPOSITION
ID25857A (en)	2000-11-09	PHARMACEUTICAL COMPOSITION
EE9800209A (en)	1998-12-15	Antiglucocorticoid drug
ITMI962628A0 (en)	1996-12-16	PHARMACEUTICAL COMPOSITION
BR9701895B1 (en)	2010-08-10	estrogenic agents and pharmaceutical composition comprising them.

Legal Events

Date	Code	Title	Description
2002-05-14	FB34	Technical and formal requirements: requirement - article 34 of industrial property law
2005-02-15	B25D	Requested change of name of applicant approved
2006-03-07	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2006-10-10	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2009-11-03	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-08-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/08/2010, OBSERVADAS AS CONDICOES LEGAIS.
2013-10-08	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.061589/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132279-24.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: WARSAW ORTHOPEDIC, WISTA LABORATORIES, WYETH, WYETH HOLDINGS CORPORATION.